As we all know, President Trump has returned to the White House after a three-day stay at Walter Reed National Military Medical Center, where he was hospitalized with COVID-19. His care is continuing around the clock in the White House Medical Unit by a team of healthcare providers led by Dr. Sean Conley, the personal physician to the President.
There continues to be a cloud of misinformation and a cloak of secrecy regarding his condition, along with questions about why he received such aggressive treatment in the hospital. President Trump is at risk for severe COVID. He’s over 65, he’s obese, and he may have other risk factors of which the public is not aware. It’s concerning to hear that he required supplemental oxygen at least twice over the weekend. His lowest oxygen levels were reported to be 93 or 94 percent. Since oxygen therapy is not routinely given for those levels, evidence-based medicine would suggest that his oxygen levels may have been lower than that.
Although the President got surprisingly aggressive medical treatment in the hospital, he appears not to have received either of the two therapeutics he has been touting publicly: hydroxychloroquine or convalescent plasma. According to news reports, in addition to taking a slew of non-prescription medications, including Vitamin D, zinc, melatonin, aspirin, and the heartburn medication Pepcid, the President was an early recipient of a series of treatments that have only been shown to improve the prognosis in patients who are severely ill with COVID.
He is on dexamethasone, a high-dose steroid. A published drug trial of more than 6,400 patients with COVID who were either receiving continuous oxygen or using a mechanical ventilator showed that a 10-day course of dexamethasone reduced 28-day mortality. But President Trump met neither of those criteria.
The President is also on remdesivir, an antiviral medication. Supplies of this drug are limited, and there’s insufficient data to recommend either for or against its use in patients with mild or moderate COVID-19. He also received a dose of an experimental antibody cocktail made by Regeneron that is designed to boost a patient’s immune system. Keep in mind: this medication has only been delivered to 275 trial patients. As I said, it’s experimental, and it has not received emergency use approval from the Food and Drug Administration (FDA). There’s no data to support the use of either of these treatments, based on the President’s reported condition.
An ethical rule in modern medicine is “first do no harm.” Did President Trump’s doctors ignore that part of the Hippocratic Oath? If these medications were truly indicated, the President was much sicker than his doctors reported. If they were not indicated, then the President is a victim of what some doctors refer to as “VIP syndrome.” VIP syndrome occurs when special treatments are given to famous or well-connected people, regardless of need or documented efficacy.
You and I can’t get the three medications that President Trump got, and that may be a good thing. One reason: the President may be the first person ever to receive all three of those treatments. The possible consequences of this combination are unknown. Another reason: studies show there is no proven benefit, and there’s the possibility of harm, in patients who received dexamethasone, but did not require continuous oxygen. Yet another reason is that high-dose dexamethasone can cause short-term, steroid-induced psychosis and other psychiatric side effects, especially in the elderly.
Just because President Trump has been discharged does not mean that he has recovered from COVID. Physicians taking care of COVID patients use the term “falling off the cliff” to describe a sudden change in acute oxygenation that can occur within the first 7-10 days of this illness. In addition to any potential side effects from the aggressive use of the medications he was given, the President is still at risk for acute worsening in his condition.
Whether he was actually sicker than reported, or he was subjected to overly aggressive “VIP” care, or determined his own time of discharge because he is the President, the next week will be critical in determining President Trump’s medical course and prognosis.
The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently issued a report titled “Medicare Advantage: Questionable Use of Health
Today is Election Day in America, the venerable time in our history when citizens of nearly all walks of life set out to cast their
Please log in to your account to comment on this article.
Join Beth Wolf, MD, CPC, CCDS, for an in-depth webcast on the FY2025 spinal fusion MS-DRG updates. Discover key changes in DRG classification, understand impacts on documentation and CMI, and learn strategies to ensure compliance.
Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.
Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.
Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.
Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.
Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks. Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.
Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.
During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.
Copyright © 2024 ICD10monitor. Powered by MedLearn Media.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
